0001069530-21-000016.txt : 20210318 0001069530-21-000016.hdr.sgml : 20210318 20210318160633 ACCESSION NUMBER: 0001069530-21-000016 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210317 FILED AS OF DATE: 20210318 DATE AS OF CHANGE: 20210318 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FRIEDMANN NADAV CENTRAL INDEX KEY: 0001245267 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-29959 FILM NUMBER: 21754394 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CASSAVA SCIENCES INC CENTRAL INDEX KEY: 0001069530 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911911336 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7801 N CAPITAL OF TEXAS HIGHWAY STREET 2: SUITE 260 CITY: AUSTIN STATE: TX ZIP: 78731 BUSINESS PHONE: 512-501-2444 MAIL ADDRESS: STREET 1: 7801 N CAPITAL OF TEXAS HIGHWAY STREET 2: SUITE 260 CITY: AUSTIN STATE: TX ZIP: 78731 FORMER COMPANY: FORMER CONFORMED NAME: PAIN THERAPEUTICS INC DATE OF NAME CHANGE: 20000309 4 1 certent-form4.xml PRIMARY DOCUMENT X0306 4 2021-03-17 0001069530 CASSAVA SCIENCES INC SAVA 0001245267 FRIEDMANN NADAV C/O CASSAVA SCIENCES, INC. 7801 N. CAPITAL OF TEXAS HWY.; SUITE 260 AUSTIN TX 78731 1 1 0 0 Chief Medical Officer Common Stock 2021-03-17 4 M 0 28015 53.55 A 92428 D Common Stock 2021-03-17 4 F 0 23996 62.52 D 68429 D Common Stock 53.55 2021-03-17 4 M 0 28015 53.55 D 2015-06-01 2021-06-01 Common Stock 28015 0 D Form 4 represents net exercise of stock options only. No shares of common stock were sold to third parties in this transaction. /s/ Eric J. Schoen by Power of Attorney 2021-03-18